Sorafenib induces partial response in metastatic ... [Acta Oncol. 2010] - PubMed

Related citations

Response to sorafenib at a low dose in patients with radioiodine-refractory pulmonary metastases from papillary thyroid carcinoma. [Thyroid. 2011]
Response to sorafenib at a low dose in patients with radioiodine-refractory pulmonary metastases from papillary thyroid carcinoma.
Chen L, Shen Y, Luo Q, Yu Y, Lu H, Zhu R. Thyroid. 2011 Feb; 21(2):119-24. Epub 2010 Dec 27.
Transient partial response to sorafenib treatment in an adolescent patient with MEN2B syndrome and end-stage medullary thyroid carcinoma. [Pediatr Blood Cancer. 2012]
Transient partial response to sorafenib treatment in an adolescent patient with MEN2B syndrome and end-stage medullary thyroid carcinoma.
Aller S, Popescu A, Rao S, Morgan E, Gosiengfiao Y. Pediatr Blood Cancer. 2012 Jan; 58(1):98-100. Epub 2011 Jun 30.
Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib. [Oncology. 2009]
Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Zimmermann K, Schmittel A, Steiner U, Asemissen AM, Knoedler M, Thiel E, Miller K, Keilholz U. Oncology. 2009; 76(5):350-4. Epub 2009 Mar 24.
Review Sorafenib: rays of hope in thyroid cancer. [Thyroid. 2010]
Review Sorafenib: rays of hope in thyroid cancer.
Duntas LH, Bernardini R. Thyroid. 2010 Dec; 20(12):1351-8. Epub 2010 Oct 18.
Review Sorafenib. [Recent Results Cancer Res. 2010]
Review Sorafenib.
Hasskarl J. Recent Results Cancer Res. 2010; 184:61-70.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
Acta Oncol. 2010 ;49(1):104-6.

PubMed
Web service access to semantic web ontologies for data annotation.
Web service access to semantic web ontologies for data annotation.
AMIA Annu Symp Proc. 2008 Nov 6 :946.

PubMed
Update of HPV-associated female genital cancers in the United States, 1999-2004.
Update of HPV-associated female genital cancers in the United States, 1999-2004.
J Womens Health (Larchmt). 2009 Nov ;18(11):1731-8.

PubMed
Characterization of a molecular chaperone present in the eukaryotic flagellum.
Characterization of a molecular chaperone present in the eukaryotic flagellum.
Eukaryot Cell. 2005 Sep ;4(9):1591-4.

PubMed
Natural calcium isotopic composition of urine as a marker of bone mineral balanc...
Natural calcium isotopic composition of urine as a marker of bone mineral balance.
Clin Chem. 2007 Jun ;53(6):1155-8. Epub 2007 Apr 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Sorafenib induces partial response in metastatic medullary thyroid carcinoma.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information